Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02819804
Title Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Northwestern University
Indications

acute lymphoblastic leukemia

Therapies

Dasatinib + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.